VetDC announces results from TANOVEA study in dogs with lymphoma

VetDC announces results from TANOVEA study in dogs with lymphoma

FORT COLLINS -- VetDC, Inc ., a veterinary cancer therapeutics company, today announced the successful conclusion of a new field study of Tanovea TM (rabacfosadine), a novel small molecule... Read More

Wednesday June 8, 2016 Tags: Fort Collins, VetDC, Steven Roy, TANOVEA, Douglas Thamm